Home: PCU 1|2003 Faculty financial interests or affiliations

Faculty financial interests or affiliations

Gerald W Chodak, MD
Grants/Research Support: AstraZeneca Pharmaceuticals LP
Consultant: AstraZeneca Pharmaceuticals LP
Speakers’ Bureau: AstraZeneca Pharmaceuticals LP

Thomas E Keane, MBBCh
Speakers’ Bureau: AstraZeneca Pharmaceuticals LP, Schering-Plough

Frank A Vicini, MD
Consultant: AstraZeneca Pharmaceuticals LP

William Kevin Kelly, DO
Grants/Research Support: Bristol-Myers Squibb Company
Speakers’ Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine and NL Communications, Inc. do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information and comparison with recommendations of other authorities. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.

 

 
   

Home

Editor’s Note

Gerald W Chodak, MD
    - Select publications

Thomas E Keane, MBBCh
    - Select publications

Frank A Vicini, MD
    - Select publications

William Kevin Kelly, DO
    - Select publications

 

Editor's Office

 
Terms of use and general disclaimer
© NL Communications, Inc. 2002. All rights reserved.